Sylebra Capital LLC increased its stake in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 19.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,796,867 shares of the company's stock after acquiring an additional 288,151 shares during the period. Xometry makes up approximately 1.1% of Sylebra Capital LLC's investment portfolio, making the stock its 18th biggest position. Sylebra Capital LLC owned 3.64% of Xometry worth $33,008,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Primecap Management Co. CA grew its position in Xometry by 1.7% in the third quarter. Primecap Management Co. CA now owns 6,918,252 shares of the company's stock worth $127,088,000 after acquiring an additional 113,264 shares in the last quarter. FMR LLC lifted its stake in Xometry by 40.2% in the third quarter. FMR LLC now owns 4,078,462 shares of the company's stock worth $74,921,000 after purchasing an additional 1,169,778 shares during the last quarter. Fred Alger Management LLC lifted its stake in Xometry by 20.8% in the third quarter. Fred Alger Management LLC now owns 1,815,696 shares of the company's stock worth $33,354,000 after purchasing an additional 312,971 shares during the last quarter. State Street Corp lifted its stake in Xometry by 0.3% in the third quarter. State Street Corp now owns 887,139 shares of the company's stock worth $16,297,000 after purchasing an additional 3,027 shares during the last quarter. Finally, Bellecapital International Ltd. bought a new stake in Xometry in the second quarter worth about $6,281,000. Hedge funds and other institutional investors own 97.31% of the company's stock.
Xometry Stock Performance
NASDAQ XMTR traded up $0.08 during trading hours on Tuesday, reaching $32.90. The stock had a trading volume of 547,492 shares, compared to its average volume of 593,880. Xometry, Inc. has a 52-week low of $11.08 and a 52-week high of $38.74. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.55 and a current ratio of 4.59. The stock has a market cap of $1.63 billion, a P/E ratio of -31.33 and a beta of 0.83. The stock has a fifty day moving average of $25.38 and a 200 day moving average of $19.10.
Insider Buying and Selling
In related news, Director Emily Rollins sold 3,729 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $29.49, for a total transaction of $109,968.21. Following the sale, the director now directly owns 12,457 shares of the company's stock, valued at approximately $367,356.93. This represents a 23.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Matthew Leibel sold 16,564 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $30.08, for a total transaction of $498,245.12. Following the sale, the chief technology officer now directly owns 77,856 shares in the company, valued at $2,341,908.48. This trade represents a 17.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 41,633 shares of company stock valued at $1,201,730. Corporate insiders own 16.79% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have issued reports on XMTR. Royal Bank of Canada raised their price objective on shares of Xometry from $23.00 to $27.00 and gave the stock a "sector perform" rating in a research note on Wednesday, November 6th. The Goldman Sachs Group raised their price objective on shares of Xometry from $24.00 to $28.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. JMP Securities lifted their price target on shares of Xometry from $34.00 to $42.00 and gave the company a "market outperform" rating in a research note on Thursday, November 14th. Citigroup lifted their price target on shares of Xometry from $25.00 to $33.00 and gave the company a "buy" rating in a research note on Wednesday, November 6th. Finally, Cantor Fitzgerald reaffirmed an "underweight" rating and set a $12.00 price target on shares of Xometry in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Xometry currently has an average rating of "Hold" and an average target price of $27.71.
View Our Latest Analysis on Xometry
About Xometry
(
Free Report)
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Featured Stories
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.